Danaher
In Brief This Week: Quest Diagnostics, Ginkgo Bioworks, Novacyt, Danaher, and More
News items for the in vitro diagnostics industry for the week of May 3, 2021.
Danaher Q1 Revenues Up 58 Percent
The firm beat the consensus Wall Street estimate on the top line as its Life Sciences revenues grew 115 percent and its Diagnostics revenue rose 34 percent.
Danaher Expects Q1 2021 Revenue Growth Above Previous Guidance
The company said it expects revenue growth to be approximately 57 percent year over year and non-GAAP core revenue growth to be approximately 29 percent.
In Brief This Week: Danaher, Guardant Health, Invitae, Yourgene Health, and More
News items for the in vitro diagnostics industry for the week of March 29, 2021.
Barclays Initiates Coverage of Danaher, Ortho, and Thermo Fisher With Overweight Ratings
Danaher’s guidance of double-digit top-line growth for 2021 provides upside opportunities that depend mostly on the success of vaccine rollouts, Barclays said.
Jan 28, 2021
Danaher Q4 Revenues up 39 Percent
Oct 22, 2020
Danaher Q3 Revenues Up 35 Percent
Sep 30, 2020
Danaher Prices $1B Senior Notes Offering
Jul 23, 2020